When UK lawmakers met recently ostensibly to debate the future of the European Medicines Agency post-Brexit, the focus was perhaps understandably on potential implications for the UK.
But some consideration was given to Brexit’s possible impact on the operations of the European Medicines Agency and more broadly...







